Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Growth 2021-2026

Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption 2016-2026
2.1.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption CAGR by Region
2.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
2.2.1 Serotype 6B
2.2.2 7F Serotype
2.2.3 Serotype 9V
2.2.4 14 Serotype
2.2.5 Serotype 18C
2.2.6 Serotype 19A
2.2.7 19F Serotype
2.2.8 23F Serotype
2.2.9 24F Serotype
2.2.10 Other
2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
2.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
2.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Type (2016-2021)
2.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Type (2016-2021)
2.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
2.4.1 Infants from 6 Weeks to 15 Months Old
2.4.2 Children Aged 15 Months to 5 Years
2.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
2.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Market Share by Application (2016-2021)
2.5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue and Market Share by Application (2016-2021)
2.5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Application (2016-2021)

3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Company
3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company
3.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Company (2019-2021)
3.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company (2019-2021)
3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company
3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Company (2019-2021)
3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company (2019-2021)
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Company
3.4 Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Location Distribution
3.4.2 Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region
4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region
4.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
4.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region
4.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth
4.3 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth
4.4 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth
4.5 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth

5 Americas
5.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
5.1.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
5.1.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
5.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
5.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
6.1.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021)
6.1.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021)
6.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
6.3 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country
7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
7.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
7.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
7.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Country
8.1.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021)
8.1.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021)
8.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type
8.3 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors
10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customer

11 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast
11.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Region
11.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Regions (2021-2026)
11.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Type
11.7 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Minhai Bio
12.2.1 Minhai Bio Company Information
12.2.2 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Minhai Bio Main Business Overview
12.2.5 Minhai Bio Latest Developments
12.3 Kexing Bio
12.3.1 Kexing Bio Company Information
12.3.2 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Kexing Bio Main Business Overview
12.3.5 Kexing Bio Latest Developments
12.4 Cansino Bio
12.4.1 Cansino Bio Company Information
12.4.2 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Cansino Bio Main Business Overview
12.4.5 Cansino Bio Latest Developments
12.5 Lanzhou Biological Preparations Institute
12.5.1 Lanzhou Biological Preparations Institute Company Information
12.5.2 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
12.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Lanzhou Biological Preparations Institute Main Business Overview
12.5.5 Lanzhou Biological Preparations Institute Latest Developments
...

13 Research Findings and Conclusion
List of Tables
Table 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Serotype 6B
Table 3. Major Players of 7F Serotype
Table 4. Major Players of Serotype 9V
Table 5. Major Players of 14 Serotype
Table 6. Major Players of Serotype 18C
Table 7. Major Players of Serotype 19A
Table 8. Major Players of 19F Serotype
Table 9. Major Players of 23F Serotype
Table 10. Major Players of 24F Serotype
Table 11. Major Players of Other
Table 12. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Type (2016-2021) & ($ million)
Table 15. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2016-2021)
Table 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Type (2016-2021)
Table 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Value by Application (2016-2021)
Table 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2016-2021)
Table 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Application (2016-2021)
Table 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Company (2019-2021) & (K Units)
Table 23. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Company (2019-2021)
Table 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Company (2019-2021) ($ Millions)
Table 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company (2019-2021)
Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sale Price by Company (2019-2021)
Table 27. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Producing Area Distribution and Sales Area
Table 28. Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Products Offered
Table 29. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021) (K Units)
Table 33. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2016-2021)
Table 34. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021) & ($ Millions)
Table 35. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2016-2021)
Table 36. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 37. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 38. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & ($ Millions)
Table 39. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 40. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 41. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 42. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 43. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 44. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2016-2021) & (K Units)
Table 45. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region (2016-2021)
Table 46. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region (2016-2021) & ($ Millions)
Table 47. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region (2016-2021)
Table 48. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 49. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 50. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 51. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 52. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 53. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 54. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 56. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 57. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 58. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 60. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country (2016-2021) & (K Units)
Table 61. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country (2016-2021)
Table 62. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country (2016-2021) & ($ Millions)
Table 63. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country (2016-2021)
Table 64. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Type (2016-2021) & (K Units)
Table 65. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
Table 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Application (2016-2021) & (K Units)
Table 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Table 68. Key and Potential Regions of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 69. Key Application and Potential Industries of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 70. Key Challenges of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 71. Key Trends of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Table 72. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List
Table 73. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customer List
Table 74. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2021-2026) & (K Units)
Table 75. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumption Market Forecast by Region
Table 76. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Region (2021-2026)
Table 78. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Region (2021-2026) & (K Units)
Table 81. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Region (2021-2026) & ($ millions)
Table 82. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2021-2026) & (K Units)
Table 83. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 84. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Country (2021-2026) & (K Units)
Table 85. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Country (2021-2026) & ($ millions)
Table 86. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Type (2021-2026) & (K Units)
Table 87. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Type (2021-2026)
Table 88. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 89. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Type (2021-2026)
Table 90. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Forecast by Application (2021-2026) & (K Units)
Table 91. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share Forecast by Application (2021-2026)
Table 92. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 93. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share Forecast by Application (2021-2026)
Table 94. Pfizer Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 96. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Minhai Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 100. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 101. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. Minhai Bio Main Business
Table 103. Minhai Bio Latest Developments
Table 104. Kexing Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 105. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 106. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. Kexing Bio Main Business
Table 108. Kexing Bio Latest Developments
Table 109. Cansino Bio Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 110. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 111. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Cansino Bio Main Business
Table 113. Cansino Bio Latest Developments
Table 114. Lanzhou Biological Preparations Institute Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Base, Sales Area and Its Competitors
Table 115. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offered
Table 116. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Lanzhou Biological Preparations Institute Main Business
Table 118. Lanzhou Biological Preparations Institute Latest Developments
List of Figures
Figure 1. Picture of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Serotype 6B
Figure 10. Product Picture of 7F Serotype
Figure 11. Product Picture of Serotype 9V
Figure 12. Product Picture of 14 Serotype
Figure 13. Product Picture of Serotype 18C
Figure 14. Product Picture of Serotype 19A
Figure 15. Product Picture of 19F Serotype
Figure 16. Product Picture of 23F Serotype
Figure 17. Product Picture of 24F Serotype
Figure 18. Product Picture of Other
Figure 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2016-2021)
Figure 21. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumed in Infants from 6 Weeks to 15 Months Old
Figure 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Infants from 6 Weeks to 15 Months Old (2016-2021) & (K Units)
Figure 23. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Consumed in Children Aged 15 Months to 5 Years
Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market: Children Aged 15 Months to 5 Years (2016-2021) & (K Units)
Figure 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
Figure 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application in 2020
Figure 27. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market by Company in 2020 ($ Million)
Figure 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Company in 2020
Figure 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Regions (2016-2021)
Figure 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Region in 2020
Figure 31. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 32. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 33. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 34. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 35. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 36. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2021 ($ Millions)
Figure 39. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2020
Figure 40. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2020
Figure 41. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 42. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 43. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Region in 2020
Figure 48. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Regions in 2020
Figure 49. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 50. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 51. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 55. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2020
Figure 58. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2020
Figure 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 60. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 61. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 62. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Country in 2020
Figure 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type in 2020
Figure 69. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application in 2020
Figure 70. Egypt 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distr

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs